C. Juno

Expression of protein phosphatase 2A mutants and silencing of the regulatory Bα subunit induce a selective loss of acetylated and detyrosinated microtubules

D. Pallas, E. Ogris, I. Mudrak, 2007, Journal of neurochemistry.

Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

H. Ehrlich, P. Knöbl, J. K. Kremer Hovinga, 2011, Journal of Thrombosis and Haemostasis.

Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management

W. Schmidt, F. Mattner, S. Brunner, 2014, PloS one.

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice

J. Jukema, E. Pieterman, J. V. D. van der Hoorn, 2017, European heart journal.

A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo.

E. Ogris, I. Mudrak, D. Lackner, 2003, Genes & development.